FDA-Approved CAR-T Therapies
In addition to the novel CAR-T therapies offered through our clinical trials program, our care team can provide our patients the following FDA-approved therapies:
- Kymriah for acute lymphoblastic leukemia or non-Hodgkin lymphoma
- Aucatzyl for acute lymphoblastic leukemia
- Yescarta for large B-cell lymphoma and follicular lymphoma
- Tecartus for mantle cell lymphoma and acute lymphoblastic leukemia
- Breyanzi for large B-cell lymphoma, follicular lymphoma, CLL, and mantle cell lymphoma
- Abecma for multiple myeloma
- Carvykti for multiple myeloma